azadirachtin
Small moleculeexperimental
Azadirachtin, a chemical compound belonging to the limonoid group, is a secondary metabolite present in neem seeds. It is a highly oxidized tetranortriterpenoid which boasts a plethora of oxygen-bearing functional groups, including an enol ether, acetal, hemiacetal, tetra-substituted epoxide and a variety of carboxylic esters. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02352987)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAzadirachtin ↗
Also known as
- azadirachtin
- azadirachtin
- azadirachtin
- azadirachtin a
- azadyrachtin
- bioneem
- neemix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06617026 | Phase 1/Phase 2 (Phase 2) | Aug 30, 2024 | Suez Canal University |
| NCT02352987 | Phase 2 | Mar 1, 2015 | Bangladesh Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bangladesh Medical University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Suez Canal University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1